Aydin Huseynov

Aydin Huseynov

#1692 out of 1697 analysts
Ladenburg Thalmann
Automatically Tracked
Tracking: 0 Updated: Jul 29 at 06:31 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-98.13%
Gain -6.09%
Monthly
-7.55%
Yearly
-61.02%
Drawdown
99.4%
$856.33
Equity
Holdings
$0
Cash
$856.33
Investment
$0
-$99,143.67
Profit -$57.04
Realized
-$99,143.67
Unrealized
$0
Dividends
$0
$856.33
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-6.09%
Profit
-$57.04
Win %
0%
This Week
Compared To Last Week
Gain
-6.25%
Profit
-$57.04
Win %
0%
This Month
Compared to last month
Gain
-24.99%
Profit
-$285.22
Win %
0%
This Year
Compared to last year
Gain
-87%
Profit
-$5,731.1
Win %
0%
Quoin Pharmaceuticals Ltd. - American Depositary Receipt logo
QNRX Quoin Pharmaceuticals Ltd. - American Depositary Receipt
+$28,953.89
Rein Therapeutics Inc. logo
RNTX Rein Therapeutics Inc.
+$4,612.64
Acrivon Therapeutics Inc. logo
ACRV Acrivon Therapeutics Inc.
+$1,618.92
Biodexa Pharmaceuticals PLC ADR logo
BDRX Biodexa Pharmaceuticals PLC ADR
+$909.68
Tempest Therapeutics Inc. logo
TPST Tempest Therapeutics Inc.
-$27,481.49
Cognition Therapeutics Inc. logo
CGTX Cognition Therapeutics Inc.
-$26,320.87
Alterity Therapeutics Limited - Depositary Receipt (Common Stock) logo
ATHE Alterity Therapeutics Limited - Depositary Receipt (Common Stock)
-$14,157.58
Nuvectis Pharma Inc. logo
NVCT Nuvectis Pharma Inc.
-$12,398.09
Marker Therapeutics, Inc. logo
MRKR Marker Therapeutics, Inc.
-$10,685.15
Palisade Bio Inc. logo
PALI Palisade Bio Inc.
-$9,008.6
Corvus Pharmaceuticals Inc. logo
CRVS Corvus Pharmaceuticals Inc.
-$5,226.39
PMV Pharmaceuticals, Inc. logo
PMVP PMV Pharmaceuticals, Inc.
-$5,141.28
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
-$4,610.41
Zura Bio Ltd. logo
ZURA Zura Bio Ltd.
-$4,239.21
Capricor Therapeutics Inc. logo
CAPR Capricor Therapeutics Inc.
-$3,829.03
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
-$3,770.96
Elicio Therapeutics Inc. logo
ELTX Elicio Therapeutics Inc.
-$2,876.63
Akari Therapeutics Plc ADR logo
AKTX Akari Therapeutics Plc ADR
-$2,495.24
Ardelyx Inc. logo
ARDX Ardelyx Inc.
-$1,965.01
Compass Therapeutics Inc. logo
CMPX Compass Therapeutics Inc.
-$673.66
Inhibikase Therapeutics Inc. logo
IKT Inhibikase Therapeutics Inc.
-$359.23
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
126
Longs Won
30/126 23%
Profit Factor
0.38
Profitability
Shorts Won
0/0 0%
Standard Deviation
$3,849.01
Average Win
$1,990.51
Best Trade
(Aug 03) $33,827.54
Sharpe Ratio
-99.97
Average Loss
-$1,654.78
Worst Trade
(Jul 31) -$12,083.84
Z-Score
-2.28 (100%)
Commissions
$0
Avg. Trade Length
1m 3w 2d
Expectancy
-$786.85
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 1 0 0 0 0 0 0 0 0 0
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit ($) Gain (%) Change
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV